Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort. [PDF]
Nathan J +21 more
europepmc +1 more source
Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab. [PDF]
Otake H, Matsumoto S, Mashima H.
europepmc +1 more source
Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry. [PDF]
Sonomoto K +9 more
europepmc +1 more source
CVB-D attenuates experimental diabetic cardiomyopathy by alleviating mitochondrial dysfunction via the JAK1-STAT1 signaling axis in vivo and in vitro. [PDF]
Su H +10 more
europepmc +1 more source
Emerging role of Janus kinase inhibitors in ulcerative colitis management. [PDF]
Ahsan MU +5 more
europepmc +1 more source
Advanced Medical Therapies for Perianal Fistulizing Crohn's Disease: A Systematic Review of Clinical, Radiological, Surgical, and Composite Outcomes. [PDF]
Jamal F +7 more
europepmc +1 more source
Monotherapy Versus Combination Therapy of Janus Kinase Inhibitors With Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) in Rheumatoid Arthritis: Evidence From a Systematic Review of Randomized Controlled Trials. [PDF]
Mirghani Idris RG +6 more
europepmc +1 more source
Comparative Efficacy of Janus Kinase Inhibitors (JAKis) for Ulcerative Colitis in Japanese Regional Healthcare Facilities: A Real-World Database Study. [PDF]
Itoi Y +16 more
europepmc +1 more source
Computational identification of small molecules for increased gene expression by synthetic circuits in mammalian cells. [PDF]
Pisani M +10 more
europepmc +1 more source
Effects of Janus Kinase Inhibitors on Rheumatoid Arthritis Pain: Clinical Evidence and Mechanistic Pathways. [PDF]
Belančić A +10 more
europepmc +1 more source

